Invention Application
- Patent Title: PROSTATE CANCER SPECIFIC INTERNALIZING HUMAN ANTIBODIES
- Patent Title (中): 前列腺癌特异性内分泌人抗体
-
Application No.: US11972130Application Date: 2008-01-10
-
Publication No.: US20090010841A1Publication Date: 2009-01-08
- Inventor: Bin Liu , James D. Marks
- Applicant: Bin Liu , James D. Marks
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Main IPC: C07K16/30
- IPC: C07K16/30 ; C07K16/46 ; A61K39/395 ; A61K51/10 ; C12N15/13 ; C12N5/10 ; G01N33/574 ; C12N5/06 ; A61P35/00

Abstract:
This invention provides novel prostate cancer specific internalizing human antibodies. The antibodies are useful by themselves to prevent growth and/or proliferation of prostate cancer cells. The antibodies can also be formulated as chimeric molecules to direct an effector (e.g. a cytotoxin, an imaging reagent, a drug, etc.) to a prostate tumor site.
Public/Granted literature
- US07582736B2 Prostate cancer specific internalizing human antibodies Public/Granted day:2009-09-01
Information query